Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles.
about
Insights into Newer Antimicrobial Agents Against Gram-negative BacteriaA medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisPenetration of fosfomycin into IPEC-J2 cells in the presence or absence of deoxynivalenolThe spectrum of latent tuberculosis: rethinking the biology and intervention strategiesIn vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.Focal Infection Treatment using Laser-Mediated Heating of Injectable Silk Hydrogels with Gold Nanoparticles.Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.Fosfomycin: Uses and potentialities in veterinary medicineFosfomycinMultidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.Fosfomycin: Resurgence of an old companion.The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae.Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens.Antibiotic-Releasing Silk Biomaterials for Infection Prevention and Treatment.Extracellular concentrations of fosfomycin in lung tissue of septic patients.High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.Fosfomycin: Pharmacological, Clinical and Future Perspectives.Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.Pharmacokinetics and Pharmacodynamics of Fosfomycin and its Activity against ESBL-, Plasmid-mediated AmpC- and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model.In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae.
P2860
Q26751255-DF8A880C-FCBF-4DEE-8C7F-3235EB502999Q27004482-FDA9E52A-5637-45BB-A8F2-ACD3208FC911Q28536930-C6CACB8B-4B51-49F0-B44D-BB665F704A04Q29619404-D5B7A92F-1935-4F22-BC49-2093D164C0B1Q33804813-3C3C367B-B62E-421A-98AF-5A3FE5C36E66Q33823864-5B73B9D8-0A70-4C37-807E-7E05F0B135D4Q34981229-1C5DB984-6DDA-476B-9828-20EE3E972B2CQ35666457-B618F4AE-5948-45CE-AF81-EA2B49F55F88Q35960788-8289D440-2A3A-4731-A78E-E0ABCF9C09C7Q36239060-C10CAE69-CF22-4C31-B155-A632A2F917EEQ36675246-6F30CCF7-9348-4425-86E1-2E56D6BDFC52Q36761826-D3F9FC8B-B0DC-4F2A-BDA4-6220E6AA2EDEQ36803694-F9227FF0-D353-4725-A85A-FC5A69D1D64CQ38689344-1E42850F-E57F-4D3A-BE2B-67F9C5242ACFQ40237248-21C389C4-E463-4202-94BA-4CE478447687Q41078268-4CEC3EE0-3613-42D2-88A9-0A2C63C37F51Q41553971-2FCBBD79-6987-47B0-86C3-41B82F317353Q43130327-22B4F439-D228-4053-8E85-6CFD07B7369AQ45939590-ED97DF5D-4C32-4401-BC39-BFF0310FAE28Q47136072-84C4A22C-E4E6-42C4-B7C4-E301B8C2E72FQ49196415-940ABCC0-E0E5-4E3A-88F2-ADE9B97F9001Q50054283-83B734E7-3F6B-4DA2-B7D8-981F18736BA2Q51734361-D7F87A72-E46A-4F7A-ABC0-5BA80CB12116Q55071894-134AC62F-8508-41D4-A088-0355D2CC7EEA
P2860
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antibiotic abscess penetration ...... d concentration-time profiles.
@ast
Antibiotic abscess penetration ...... d concentration-time profiles.
@en
Antibiotic abscess penetration ...... d concentration-time profiles.
@nl
type
label
Antibiotic abscess penetration ...... d concentration-time profiles.
@ast
Antibiotic abscess penetration ...... d concentration-time profiles.
@en
Antibiotic abscess penetration ...... d concentration-time profiles.
@nl
prefLabel
Antibiotic abscess penetration ...... d concentration-time profiles.
@ast
Antibiotic abscess penetration ...... d concentration-time profiles.
@en
Antibiotic abscess penetration ...... d concentration-time profiles.
@nl
P2093
P2860
P1476
Antibiotic abscess penetration ...... d concentration-time profiles.
@en
P2093
Bernhard Mayer-Helm
Christian Joukhadar
Claudia Wagner
Georgios Karanikas
Herbert Langenberger
Joachim Kettenbach
Martina Petsch
Rainer Gattringer
Robert Sauermann
Rudolf Karch
P2860
P304
P356
10.1128/AAC.49.11.4448-4454.2005
P407
P577
2005-11-01T00:00:00Z